BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22990106)

  • 1. Identification of markers associated with highly aggressive metastatic phenotypes using quantitative comparative proteomics.
    Terp MG; Lund RR; Jensen ON; Leth-Larsen R; Ditzel HJ
    Cancer Genomics Proteomics; 2012; 9(5):265-73. PubMed ID: 22990106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
    Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
    J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomics of primary tumors with varying metastatic capabilities using stable isotope-labeled proteins of multiple histogenic origins.
    Lund RR; Terp MG; Laenkholm AV; Jensen ON; Leth-Larsen R; Ditzel HJ
    Proteomics; 2012 Jul; 12(13):2139-48. PubMed ID: 22623409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry.
    Leth-Larsen R; Lund R; Hansen HV; Laenkholm AV; Tarin D; Jensen ON; Ditzel HJ
    Mol Cell Proteomics; 2009 Jun; 8(6):1436-49. PubMed ID: 19321434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells.
    Cooney CA; Jousheghany F; Yao-Borengasser A; Phanavanh B; Gomes T; Kieber-Emmons AM; Siegel ER; Suva LJ; Ferrone S; Kieber-Emmons T; Monzavi-Karbassi B
    Breast Cancer Res; 2011 Jun; 13(3):R58. PubMed ID: 21658254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.
    Urquidi V; Sloan D; Kawai K; Agarwal D; Woodman AC; Tarin D; Goodison S
    Clin Cancer Res; 2002 Jan; 8(1):61-74. PubMed ID: 11801541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer.
    Klopfleisch R; Klose P; Weise C; Bondzio A; Multhaup G; Einspanier R; Gruber AD
    J Proteome Res; 2010 Dec; 9(12):6380-91. PubMed ID: 20932060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry.
    Li DQ; Wang L; Fei F; Hou YF; Luo JM; ; Zeng R; Wu J; Lu JS; Di GH; Ou ZL; Xia QC; Shen ZZ; Shao ZM
    Proteomics; 2006 Jun; 6(11):3352-68. PubMed ID: 16637015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scanning the cell surface proteome of cancer cells and identification of metastasis-associated proteins using a subtractive immunization strategy.
    Rasmussen N; Ditzel HJ
    J Proteome Res; 2009 Nov; 8(11):5048-59. PubMed ID: 19764822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proteomics study on human breast cancer cell lines by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry.
    Imai K; Ichibangase T; Saitoh R; Hoshikawa Y
    Biomed Chromatogr; 2008 Nov; 22(11):1304-14. PubMed ID: 18821527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines.
    Ghosh D; Yu H; Tan XF; Lim TK; Zubaidah RM; Tan HT; Chung MC; Lin Q
    J Proteome Res; 2011 Oct; 10(10):4373-87. PubMed ID: 21854069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
    Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
    Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.
    Sin S; Bonin F; Petit V; Meseure D; Lallemand F; Bièche I; Bellahcène A; Castronovo V; de Wever O; Gespach C; Lidereau R; Driouch K
    J Natl Cancer Inst; 2011 Sep; 103(17):1323-37. PubMed ID: 21832234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel breast cancer metastasis-associated proteins.
    Ho J; Kong JW; Choong LY; Loh MC; Toy W; Chong PK; Wong CH; Wong CY; Shah N; Lim YP
    J Proteome Res; 2009 Feb; 8(2):583-94. PubMed ID: 19086899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
    Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
    J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of membrane and membrane-bound proteins in normal and malignant breast cancer cells isolated from the same patient with primary breast carcinoma.
    Liang X; Zhao J; Hajivandi M; Wu R; Tao J; Amshey JW; Pope RM
    J Proteome Res; 2006 Oct; 5(10):2632-41. PubMed ID: 17022634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of the membrane proteome of closely related metastatic and nonmetastatic tumor cells.
    Roesli C; Borgia B; Schliemann C; Gunthert M; Wunderli-Allenspach H; Giavazzi R; Neri D
    Cancer Res; 2009 Jul; 69(13):5406-14. PubMed ID: 19491280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.